TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA PEN NEEDLES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELING
2.8 PRODUCTS LIFELINE CURVE
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 RISING GOVERNMENT INITIATIVES
3.2 RESTRAINT
3.2.1 PREFERENCE FOR ALTERNATIVE MODES OF DRUG DELIVERY
3.3 OPPORTUNITIES
3.3.1 RISE IN AWARENESS AMONG THE POPULATION
3.3.2 INCREASING BIOSIMILAR DRUG AVAILABILITY
3.4 CHALLENGES
3.4.1 REUSE OF PEN NEEDLES
3.4.2 STRICT REGULATORY REQUIREMENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 STANDARD PEN NEEDLES
6.3 SAFETY PEN NEEDLES
7 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY PRODUCT LENGTH
7.1 OVERVIEW
7.2 MEDIUM LENGTH
7.3 NANO LENGTH
7.4 LONG LENGTH
8 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY USABILITY
8.1 OVERVIEW
8.2 REUSABLE
8.3 DISPOSABLE
9 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DIABETES
9.3 GROWTH HORMONE DEFICIENCY
9.4 OTHERS
10 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY THERAPY
10.1 OVERVIEW
10.2 INSULIN
10.3 GLUCAGON-LIKE PEPTIDE-1
10.4 GROWTH HORMONES
10.5 OTHERS
11 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOME HEALTHCARE
11.3 HOSPITALS
11.4 CLINICS
11.5 OTHERS
?
12 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, BY GEOGRAPHY
12.1 MIDDLE EAST & AFRICA
12.1.1 SOUTH AFRICA
12.1.2 REST OF MIDDLE EAST & AFRICA
12.1.3 EGYPT
12.1.4 SAUDI ARAIA
12.1.5 UNITED ARAB EMIRATES
12.1.6 ISRAEL
13 MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
14 COMPANY PROFILE
14.1 NOVO NORDISK A/S
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 SANOFI
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 ELI LILLY AND COMPANY
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 BD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
?
14.5 A. MENARINI DIAGNOSTICS SRL
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 ALLISON MEDICAL, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 B. BRAUN MELSUNGEN AG
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 DIGITAL MEDICS PTY LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 DOMREX PHARMA INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 FACET MEDICAL TECHNOLOGIES
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 HTL- STREFA S.A.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 KD MEDICAL GMBH HOSPITAL PRODUCTS
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 LDI LTD., LLC
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
?
14.14 MEDEXEL CO., LTD.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 OWEN MUMFORD LTD
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 PENDIQ GMBH
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 STAT MEDICAL DEVICES.
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 TERUMO CORPORATION
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 VOGT MEDICAL
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.20 WILHELM HASELMEIER GMBH & CO. KG
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 YPSOMED AG
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS